Ready to Register?

MyLawCLE All-Access Pass

Best choice

Add the All-Access Pass and get this program —
plus 1,000+ live CLE programs every year.


All specialty & ethics credits included
38 practice areas
New sections: AI & the Law, Practice Management
100s of current and trending legal topics
Nationally recognized and highly experienced presenters

$395 / year — this program included
Register with the All-Access Pass

This program + 1,000+ CLE programs, all year

Or register for just this program

On-Demand Video

Recorded access + self-study credit.
$195 Register

The Science of Alcohol Intoxication: Navigating Dram Shop and Liquor Liability

Master alcohol toxicology and dram shop liability. Gain expert-backed skills to interpret toxicology results, collaborate with witnesses, and win alcohol-related cases

2026-02-19 13:00:00

Program Details

2026-02-19 13:00:00

Program Details

2026-02-19 13:00:00

Over 1,000+ webinars

2026-02-19 13:00:00

Course Overview

Mastering Alcohol Toxicology for Dram Shop Litigation

2026-02-19 13:00:00

Attorneys will learn alcohol toxicology science, dram shop liability, and how to work effectively with expert witnesses in alcohol-related civil and criminal cases.

Format

CLE Credit

2h CLE Credits

Level

Intermediate

Length

2

Key topics that will be covered

01
Alcohol Toxicology
A foundational review of alcohol toxicology principles.
02
Pharmacokinetics
What the body does to alcohol.
03
Pharmacodynamics
What alcohol does to the body
04
Dram shop
Analysis of dram shop liability for alcohol-related legal matters.
05
Toxicologist role
Information toxicologists need from attorneys to analyze alcohol-related cases.
06
Case collaboration
How attorneys can better collaborate with experts for stronger representation.

Program schedule

clock 1:00 pm - 1:20 pm EST

Review of Alcohol Toxicology

Build a foundational understanding of alcohol toxicology, including key scientific principles and terminology that attorneys need to effectively evaluate intoxication evidence and expert testimony in alcohol-related civil and criminal cases.

David M. LehmannDavid M. Lehmann
Heidy O’NeilHeidy O’Neil
Michael J. LaszloMichael J. Laszlo
Patrick MaroneyPatrick Maroney
clock 1:20 pm - 1:40 pm EST

What The Body Does to Alcohol

Examine how the body absorbs, distributes, and eliminates alcohol, and how these pharmacokinetic processes directly impact BAC calculations, timeline reconstruction, and the liability arguments attorneys must address in alcohol-related civil litigation.

David M. LehmannDavid M. Lehmann
Heidy O’NeilHeidy O’Neil
Michael J. LaszloMichael J. Laszlo
Patrick MaroneyPatrick Maroney
clock 1:40 pm - 2:00 pm EST

What Alcohol Does to the Body

Explore alcohol’s pharmacodynamic effects on human physiology and behavior, giving attorneys the scientific foundation they need to evaluate impairment claims, challenge opposing experts, and build stronger representation in alcohol-related cases.

David M. LehmannDavid M. Lehmann
Heidy O’NeilHeidy O’Neil
Michael J. LaszloMichael J. Laszlo
Patrick MaroneyPatrick Maroney
clock 2:10 pm - 2:30 pm EST

Dram Shop Liability

Analyze how civil liability attaches to alcohol-serving establishments under dram shop laws and learn how these statutes apply across both plaintiff and defense strategies in personal injury and wrongful death litigation.

David M. LehmannDavid M. Lehmann
Heidy O’NeilHeidy O’Neil
Michael J. LaszloMichael J. Laszlo
Patrick MaroneyPatrick Maroney
clock 2:30 pm - 2:50 pm EST

The Role of Toxicologists in Alcohol-Related Legal Cases

Discover what critical information toxicologists need from attorneys and learn how to effectively collaborate with expert witnesses to interpret complex scientific findings and build stronger arguments in alcohol-related legal cases today.

David M. LehmannDavid M. Lehmann
Heidy O’NeilHeidy O’Neil
Michael J. LaszloMichael J. Laszlo
Patrick MaroneyPatrick Maroney
clock 2:50 pm - 3:10 pm EST

Key Takeaways and Practitioner Q&A Session

Review essential principles including state-specific dram shop requirements, the distinction between visible intoxication and consumption amounts, and the critical role of experts. Engage in Q&A to address specific practitioner questions and case scenarios.

David M. LehmannDavid M. Lehmann
Heidy O’NeilHeidy O’Neil
Michael J. LaszloMichael J. Laszlo
Patrick MaroneyPatrick Maroney
David M. Lehmann

David M. Lehmann

Intertox Inc

Heidy O’Neil

Heidy O’Neil

Intertox Inc

Michael J. Laszlo

Michael J. Laszlo

Clark Hill PLC

Patrick Maroney

Patrick Maroney

Maroney Consulting Services LLC

David M. Lehmann

David M. Lehmann

Intertox Inc

David M. Lehmann, Ph.D., is a distinguished toxicologist with nearly two decades of multidisciplinary experience spanning academia, industry, and government. As a Senior Toxicologist at Intertox, Inc., he specializes in evaluating human health risks associated with environmental pollutants, alcohol and drugs, medical devices, and consumer products. Equally accomplished as a laboratory scientist and a written communicator, Dr. Lehmann brings a rare combination of investigational rigor and analytical clarity to every engagement — making him a trusted resource for clients navigating complex regulatory, litigation, and public health challenges.

Education & Credentials

Dr. Lehmann earned his Bachelor of Science in Biology from Colorado State University before pursuing advanced training at the University of Rochester School of Medicine and Dentistry, where he completed both his Master of Science and Doctor of Philosophy in Toxicology. He subsequently completed a PostDoctoral Appointment in Pharmacology, also at the University of Rochester School of Medicine and Dentistry, further deepening his expertise in drug-related mechanisms and human physiological responses.

Recognition & Leadership

Dr. Lehmann is internationally recognized for his contributions to the development and validation of new approach methodologies (NAMs) and non-animal testing methods. He has been selected as a contributor to ICCVAM, the Interagency Coordinating Committee on the Validation of Alternative Methods, and has served as an expert panel member for OECD working groups charged with developing new toxicological test guidelines across critical endpoints — including skin sensitization, respiratory sensitization, immunotoxicology, and skin and eye irritation. His appointment to international peer review panels for non-animal toxicity testing methods reflects the scientific community's confidence in his expertise and judgment, and his work in this space continues to shape the future of regulatory toxicology on a global scale.

Professional Involvement

Beyond his client-facing work, Dr. Lehmann is an engaged and active contributor to the broader scientific community. Through his ongoing roles with ICCVAM and OECD expert groups, he participates in federal interagency and international initiatives aimed at advancing the validation and regulatory acceptance of alternative test methods. He also serves as a peer reviewer for international toxicity testing methodologies and validation programs. A committed educator and communicator, Dr. Lehmann is recognized for his ability to translate complex toxicological science for a wide range of audiences — from undergraduate and graduate students to industry professionals, policymakers, and community stakeholders.

Experience

Dr. Lehmann joined Intertox, Inc. in 2025, bringing with him a career built on scientific excellence across research, regulatory science, and applied consulting. His investigational expertise spans a broad range of toxicological endpoints, including respiratory and contact hypersensitivity reactions, immunosuppression, hematology, skin and eye irritation, cytotoxicity, genotoxicity, and the effects of insecticides on pollinator health. In the area of human health risk assessment, he applies weight-of-evidence frameworks — including the Bradford Hill criteria — to causation analyses involving pesticides, metals, medical devices, and other chemical agents, delivering defensible and regulatory-ready evaluations. His background in pharmacology and cellular mechanisms further supports both clinical and non-clinical risk assessments involving drug-related signal transduction pathways. Dr. Lehmann is also experienced in designing, conducting, and interpreting in vivo and in vitro toxicology studies built to satisfy regulatory requirements, and he is skilled in systematic review and evidence mapping — conducting comprehensive literature searches and producing the evidence maps that underpin robust risk assessments. Throughout his career, Dr. Lehmann has consistently demonstrated an exceptional ability to address multifaceted scientific questions with precision, clarity, and a proven commitment to serving client needs.
Heidy O’Neil

Heidy O’Neil

Intertox Inc

Heidi C. O’Neill, Ph.D., DABT, is a highly accomplished toxicologist with more than two decades of experience investigating the effects of chemical compounds on human health — both as pharmacological therapeutics with the potential to benefit and as toxicants with the potential to harm. As a Senior Toxicologist at Intertox, Inc., Dr. O’Neill brings deep expertise in human health risk assessment for consumer products, industrial chemicals, and regulated substances, with a particular focus on flavoring compounds, solvents, organophosphates, pesticides, and extractable and leachable chemicals. Her career reflects an exceptional ability to translate complex toxicological science into practical, defensible guidance for regulatory, litigation, and industry audiences alike.

Education & Credentials

Dr. O'Neill earned her Bachelor of Science in Psychology from the University of Colorado, Denver, before pursuing advanced scientific training at the University of Colorado School of Medicine, where she completed her Doctor of Philosophy in Toxicology. She holds board certification as a Diplomate of the American Board of Toxicology (DABT), a prestigious credential that recognizes demonstrated competency and professional excellence in the science of toxicology.

Recognition & Leadership

Dr. O'Neill's board certification as a Diplomate of the American Board of Toxicology reflects the professional community's recognition of her expertise and commitment to the highest standards of scientific practice. Over the course of her career, she has taken on increasingly complex roles in human health risk assessment, regulatory science, and litigation support — establishing herself as a sought-after expert across both consumer product and industrial settings. Notably, she has contributed to the development of innovative internal safety systems, including laying the groundwork for a Safety Data Sheet (SDS) screening framework designed to build a comprehensive database supporting go/no-go decisions for worker safety at a major food company.

Professional Involvement

Dr. O'Neill is an engaged member of the toxicology and regulatory science communities. Her professional work encompasses collaboration with industry stakeholders, regulatory bodies, and legal teams across a wide range of disciplines. She has played an active role in supporting FDA regulatory submissions for tobacco products — both oral and inhaled — and has contributed expert toxicological analyses in support of legal proceedings. Her breadth of involvement across consumer product safety, pharmaceutical product assessment, and occupational health reflects a career defined by interdisciplinary engagement and a consistent commitment to advancing science-based decision making.

Experience

Dr. O'Neill joined Intertox, Inc. in 2024, bringing with her more than twenty years of experience at the intersection of toxicology, regulatory science, and applied risk assessment. Her practice spans human health risk assessment for a diverse portfolio of consumer products — including tobacco products, cannabis vape products, food, and personal care products — as well as toxicological evaluations in industrial and pharmaceutical settings. She has particular expertise in evaluating the health risks posed by f lavoring compounds in oral, food, and inhalation products, and in assessing solvents, organophosphates, and pesticides for their potential impacts on human health. Dr. O'Neill has extensive experience preparing FDA submissions for consumer products, with a specialized focus on both inhaled and oral nicotine products, and she is well-versed in the regulatory landscape governing these categories. She also conducts toxicological evaluations to support extractable and leachable chemical assessments and performs product stewardship reviews for a wide range of chemical compounds. Rounding out her practice, Dr. O'Neill provides expert scientific support in litigation matters, offering well-reasoned, evidence-based toxicological analyses that serve the needs of legal teams and their clients.
Michael J. Laszlo

Michael J. Laszlo

Clark Hill PLC

Mike Laszlo is an accomplished litigator and business counselor who focuses his practice on the food, beverage, and hospitality industries, representing restaurant groups, wineries, distilleries, breweries, importers, wholesalers, and retailers.

Recognition & Leadership

Frequent speaker and commentator on alcohol beverage law and business and commercial law.

Professional Involvement

Extensive experience in alternative dispute resolution including mediation and arbitration.

Experience

Represents businesses in all aspects of the food, beverage, and hospitality industry including corporate and commercial matters, litigation, complex liquor licensing and three-tier issues, and alcohol franchise laws. Extensive experience at all stages of litigation including trials and appeals. Has served in business roles over the years. Advises startups and industry juggernauts on corporate and commercial transactions, trademarks, and complex business matters.
Patrick Maroney

Patrick Maroney

Maroney Consulting Services LLC

Patrick Maroney is the President of Maroney Consulting Services LLC, providing consulting related to liquor laws, rules, liability, training and compliance for liquor licenses and stakeholders with over 33 years of experience in law enforcement and regulatory compliance.

Professional Involvement

Former board member of the National Conference of State Liquor Administrators (NCSLA). Served on several panels during NCSLA conferences and hosted the 2017 National Conference in Denver.

Experience

Over 33 years of experience in law enforcement and regulatory compliance. Retired from the state of Colorado in June 2019 where he served as Director for the Colorado Liquor Enforcement Division (LED) since 2013. Previously served as Chief of Investigations for LED for over two years. Worked for Colorado Lottery, Colorado Bureau of Investigation, Arapahoe County Coroner's Office, and Larimer County Sheriff's Office. Worked closely with liquor stakeholders in 2016 and 2018 to implement two bills that brought significant changes to Colorado's liquor laws.
David M. Lehmann

David M. Lehmann

Intertox Inc

David M. Lehmann, Ph.D., is a distinguished toxicologist with nearly two decades of multidisciplinary experience spanning academia, industry, and government. As a Senior Toxicologist at Intertox, Inc., he specializes in evaluating human health risks associated with environmental pollutants, alcohol and drugs, medical devices, and consumer products. Equally accomplished as a laboratory scientist and a written communicator, Dr. Lehmann brings a rare combination of investigational rigor and analytical clarity to every engagement — making him a trusted resource for clients navigating complex regulatory, litigation, and public health challenges.

Education & Credentials

Dr. Lehmann earned his Bachelor of Science in Biology from Colorado State University before pursuing advanced training at the University of Rochester School of Medicine and Dentistry, where he completed both his Master of Science and Doctor of Philosophy in Toxicology. He subsequently completed a PostDoctoral Appointment in Pharmacology, also at the University of Rochester School of Medicine and Dentistry, further deepening his expertise in drug-related mechanisms and human physiological responses.

Recognition & Leadership

Dr. Lehmann is internationally recognized for his contributions to the development and validation of new approach methodologies (NAMs) and non-animal testing methods. He has been selected as a contributor to ICCVAM, the Interagency Coordinating Committee on the Validation of Alternative Methods, and has served as an expert panel member for OECD working groups charged with developing new toxicological test guidelines across critical endpoints — including skin sensitization, respiratory sensitization, immunotoxicology, and skin and eye irritation. His appointment to international peer review panels for non-animal toxicity testing methods reflects the scientific community's confidence in his expertise and judgment, and his work in this space continues to shape the future of regulatory toxicology on a global scale.

Professional Involvement

Beyond his client-facing work, Dr. Lehmann is an engaged and active contributor to the broader scientific community. Through his ongoing roles with ICCVAM and OECD expert groups, he participates in federal interagency and international initiatives aimed at advancing the validation and regulatory acceptance of alternative test methods. He also serves as a peer reviewer for international toxicity testing methodologies and validation programs. A committed educator and communicator, Dr. Lehmann is recognized for his ability to translate complex toxicological science for a wide range of audiences — from undergraduate and graduate students to industry professionals, policymakers, and community stakeholders.

Experience

Dr. Lehmann joined Intertox, Inc. in 2025, bringing with him a career built on scientific excellence across research, regulatory science, and applied consulting. His investigational expertise spans a broad range of toxicological endpoints, including respiratory and contact hypersensitivity reactions, immunosuppression, hematology, skin and eye irritation, cytotoxicity, genotoxicity, and the effects of insecticides on pollinator health. In the area of human health risk assessment, he applies weight-of-evidence frameworks — including the Bradford Hill criteria — to causation analyses involving pesticides, metals, medical devices, and other chemical agents, delivering defensible and regulatory-ready evaluations. His background in pharmacology and cellular mechanisms further supports both clinical and non-clinical risk assessments involving drug-related signal transduction pathways. Dr. Lehmann is also experienced in designing, conducting, and interpreting in vivo and in vitro toxicology studies built to satisfy regulatory requirements, and he is skilled in systematic review and evidence mapping — conducting comprehensive literature searches and producing the evidence maps that underpin robust risk assessments. Throughout his career, Dr. Lehmann has consistently demonstrated an exceptional ability to address multifaceted scientific questions with precision, clarity, and a proven commitment to serving client needs.
Heidy O’Neil

Heidy O’Neil

Intertox Inc

Heidi C. O’Neill, Ph.D., DABT, is a highly accomplished toxicologist with more than two decades of experience investigating the effects of chemical compounds on human health — both as pharmacological therapeutics with the potential to benefit and as toxicants with the potential to harm. As a Senior Toxicologist at Intertox, Inc., Dr. O’Neill brings deep expertise in human health risk assessment for consumer products, industrial chemicals, and regulated substances, with a particular focus on flavoring compounds, solvents, organophosphates, pesticides, and extractable and leachable chemicals. Her career reflects an exceptional ability to translate complex toxicological science into practical, defensible guidance for regulatory, litigation, and industry audiences alike.

Education & Credentials

Dr. O'Neill earned her Bachelor of Science in Psychology from the University of Colorado, Denver, before pursuing advanced scientific training at the University of Colorado School of Medicine, where she completed her Doctor of Philosophy in Toxicology. She holds board certification as a Diplomate of the American Board of Toxicology (DABT), a prestigious credential that recognizes demonstrated competency and professional excellence in the science of toxicology.

Recognition & Leadership

Dr. O'Neill's board certification as a Diplomate of the American Board of Toxicology reflects the professional community's recognition of her expertise and commitment to the highest standards of scientific practice. Over the course of her career, she has taken on increasingly complex roles in human health risk assessment, regulatory science, and litigation support — establishing herself as a sought-after expert across both consumer product and industrial settings. Notably, she has contributed to the development of innovative internal safety systems, including laying the groundwork for a Safety Data Sheet (SDS) screening framework designed to build a comprehensive database supporting go/no-go decisions for worker safety at a major food company.

Professional Involvement

Dr. O'Neill is an engaged member of the toxicology and regulatory science communities. Her professional work encompasses collaboration with industry stakeholders, regulatory bodies, and legal teams across a wide range of disciplines. She has played an active role in supporting FDA regulatory submissions for tobacco products — both oral and inhaled — and has contributed expert toxicological analyses in support of legal proceedings. Her breadth of involvement across consumer product safety, pharmaceutical product assessment, and occupational health reflects a career defined by interdisciplinary engagement and a consistent commitment to advancing science-based decision making.

Experience

Dr. O'Neill joined Intertox, Inc. in 2024, bringing with her more than twenty years of experience at the intersection of toxicology, regulatory science, and applied risk assessment. Her practice spans human health risk assessment for a diverse portfolio of consumer products — including tobacco products, cannabis vape products, food, and personal care products — as well as toxicological evaluations in industrial and pharmaceutical settings. She has particular expertise in evaluating the health risks posed by f lavoring compounds in oral, food, and inhalation products, and in assessing solvents, organophosphates, and pesticides for their potential impacts on human health. Dr. O'Neill has extensive experience preparing FDA submissions for consumer products, with a specialized focus on both inhaled and oral nicotine products, and she is well-versed in the regulatory landscape governing these categories. She also conducts toxicological evaluations to support extractable and leachable chemical assessments and performs product stewardship reviews for a wide range of chemical compounds. Rounding out her practice, Dr. O'Neill provides expert scientific support in litigation matters, offering well-reasoned, evidence-based toxicological analyses that serve the needs of legal teams and their clients.
Michael J. Laszlo

Michael J. Laszlo

Clark Hill PLC

Mike Laszlo is an accomplished litigator and business counselor who focuses his practice on the food, beverage, and hospitality industries, representing restaurant groups, wineries, distilleries, breweries, importers, wholesalers, and retailers.

Recognition & Leadership

Frequent speaker and commentator on alcohol beverage law and business and commercial law.

Professional Involvement

Extensive experience in alternative dispute resolution including mediation and arbitration.

Experience

Represents businesses in all aspects of the food, beverage, and hospitality industry including corporate and commercial matters, litigation, complex liquor licensing and three-tier issues, and alcohol franchise laws. Extensive experience at all stages of litigation including trials and appeals. Has served in business roles over the years. Advises startups and industry juggernauts on corporate and commercial transactions, trademarks, and complex business matters.
Patrick Maroney

Patrick Maroney

Maroney Consulting Services LLC

Patrick Maroney is the President of Maroney Consulting Services LLC, providing consulting related to liquor laws, rules, liability, training and compliance for liquor licenses and stakeholders with over 33 years of experience in law enforcement and regulatory compliance.

Professional Involvement

Former board member of the National Conference of State Liquor Administrators (NCSLA). Served on several panels during NCSLA conferences and hosted the 2017 National Conference in Denver.

Experience

Over 33 years of experience in law enforcement and regulatory compliance. Retired from the state of Colorado in June 2019 where he served as Director for the Colorado Liquor Enforcement Division (LED) since 2013. Previously served as Chief of Investigations for LED for over two years. Worked for Colorado Lottery, Colorado Bureau of Investigation, Arapahoe County Coroner's Office, and Larimer County Sheriff's Office. Worked closely with liquor stakeholders in 2016 and 2018 to implement two bills that brought significant changes to Colorado's liquor laws.

Credits by state

AK2.0
AL2.0
AR2.0
AZ2.0
CA2.0
CO2.0
CT2.0
DC2.0
DE2.0
FL2.0
GA2.0
HI2.0
IA2.0
ID2.0
IL2.0
IN2.0
KS2.0
KY2.0
LA2.0
MA2.0
MD2.0
ME2.0
MI2.0
MN2.0
MO2.4
MS2.0
MT2.0
NC2.0
ND2.0
NE2.0
NH120.0
NJ2.4
NM2.0
NV2.0
NY2.0
OH2.0
OK2.5
OR2.0
PA2.0
RI2.5
SC2.0
SD2.0
TN2.0
TX2.0
UT2.0
VA2.0
VT2.0
WA2.0
WI2.0
WV2.4
WY2.0

Upcoming Live Online CLE Broadcasts

1000+

Live stream programs

24/7

Access to live webinars & recordings

70,000+

Trusted by Legal Professionals

1000+

Live stream programs

24/7

Access to live webinars & recordings

70,000+

Trusted by Legal Professionals

1000+

Live stream programs

24/7

Access to live webinars & recordings

10,000+

Trusted by Legal Professionals

1000+

Live stream programs

24/7

Access to live webinars & recordings

70,000+

Trusted by Legal Professionals

MCLE Credits

Alabama
Approved
Alaska
Approved
Arizona
Approved
Arkansas
Approved
California
Approved
Colorado
Pending
Connecticut
Approved
Delaware
Pending
District of Columbia
No Required
Florida
Approved
Georgia
Approved
Hawaii
Approved
Idaho
Pending
Illinois
Approved
Indiana
Approved
Iowa
Pending
Kansas
Pending
Kentucky
Pending
Louisiana
Pending
Maine
Pending
Maryland
No Required
Massachusetts
No Required
Michigan
No Required
Minnesota
Approved
Mississippi
Pending
Missouri
Approved
Montana
Pending
Nebraska
Pending
Nevada
Approved
New Hampshire
Approved
New Jersey
Approved
New Mexico
Approved
New York
Approved
North Carolina
Pending
North Dakota
Approved
Ohio
Approved
Oklahoma
Pending
Oregon
Approved
Pennsylvania
Approved
Rhode Island
Pending
South Carolina
Pending
South Dakota
No Required
Tennessee
Approved
Texas
Approved
Utah
Pending
Vermont
Approved
Virginia
Not Eligible
Washington
Approved
West Virginia
Pending
Wisconsin
Approved
Wyoming
Approved

Alabama

Requirements

The Alabama State Bar MCLE Commission requires attorneys to complete 12 credits, including 1 ethics, by December 31 of each year. All credits must be reported by February 15 of the following year. A maximum of 12 credits, including 1 ethics credit, may be carried over for 1 year only.  

Formats

  • Attorneys can earn unlimited “live” credit through live seminars, live webcasts, and co-sponsored locations with MyLAWCLE-Alabama approved programs
  • Attorneys are limited to 6 credits per compliance period of “online” programs through MyLAwCLE On-Demand programs